Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials.

Kotecha D, Ngo K, Walters JA, Manzano L, Palazzuoli A, Flather MD.

Am Heart J. 2011 May;161(5):822-831.e2. doi: 10.1016/j.ahj.2011.02.013. Review.

PMID:
21570510
2.

Correcting anemia in heart failure: the efficacy and safety of erythropoiesis-stimulating agents.

Lawler PR, Filion KB, Eisenberg MJ.

J Card Fail. 2010 Aug;16(8):649-58. doi: 10.1016/j.cardfail.2010.03.013. Epub 2010 May 14. Review.

PMID:
20670844
3.

Erythropoiesis-stimulating agents and heart failure.

Lipšic E, van der Meer P, van Veldhuisen DJ.

Cardiovasc Ther. 2011 Aug;29(4):e52-9. doi: 10.1111/j.1755-5922.2010.00240.x. Epub 2010 Oct 26. Review.

PMID:
20973926
4.

Use of erythropoietin in heart failure management.

Caiola K, Cheng JW.

Ann Pharmacother. 2004 Dec;38(12):2145-9. Epub 2004 Oct 19. Review.

PMID:
15494385
5.

Treatment of anemia in patients with chronic heart failure.

Katz SD, Mancini D, Androne AS, Hryniewicz K.

J Card Fail. 2004 Feb;10(1 Suppl):S13-6. Review.

PMID:
15007795
6.

Etiology and management of anemia in patients with heart failure: how much iron is missing?

Beck da Silva L, Rohde LE, Clausell N.

Congest Heart Fail. 2008 Jan-Feb;14(1):25-30. Review.

PMID:
18256566
7.

Anemia in heart failure:current evidence and challenges.

Tang WH.

Rev Cardiovasc Med. 2007 Spring;8(2):78-86. Review.

PMID:
17603426
8.

Congestive heart failure-related anemia and a role for erythropoietin.

Akram K, Pearlman BL.

Int J Cardiol. 2007 May 2;117(3):296-305. Epub 2006 Aug 9. Review.

PMID:
16901559
9.

Anemia in chronic congestive heart failure: frequency, prognosis, and treatment.

Crosato M, Steinborn W, Anker SD.

Heart Fail Monit. 2003;4(1):2-6. Review.

PMID:
12808478
10.

Anemia in chronic heart failure.

Drakos SG, Anastasiou-Nana MI, Malliaras KG, Nanas JN.

Congest Heart Fail. 2009 Mar-Apr;15(2):87-92. doi: 10.1111/j.1751-7133.2009.00049.x. Review.

11.

Erythropoietin in chronic heart failure.

Belonje AM, Voors AA, van Gilst WH, van Veldhuisen DJ.

Congest Heart Fail. 2007 Sep-Oct;13(5):289-92. Review.

12.

Anemia and chronic heart failure implications and treatment options.

Anand IS.

J Am Coll Cardiol. 2008 Aug 12;52(7):501-11. doi: 10.1016/j.jacc.2008.04.044. Review.

13.

Recognition and treatment of anemia in the setting of heart failure due to systolic left ventricular dysfunction.

Howlett JG.

Expert Rev Cardiovasc Ther. 2008 Feb;6(2):199-208. doi: 10.1586/14779072.6.2.199. Review.

PMID:
18248274
14.

The use of erythropoiesis-stimulating agents in patients with non-myeloid hematological malignancies: a systematic review.

Shehata N, Walker I, Meyer R, Haynes AE, Imrie K; Cancer Care Ontario Hematology Disease Site Group.

Ann Hematol. 2008 Dec;87(12):961-73. doi: 10.1007/s00277-008-0525-5. Epub 2008 Jul 16. Review.

PMID:
18629499
15.

Latest strategy in renal anemia management in peritoneal dialysis patients.

Lo WK.

Perit Dial Int. 2008 Jun;28 Suppl 3:S76-80.

PMID:
18552270
16.

Continuous erythropoietin receptor activator (Mircera) for renal anemia.

McGahan L.

Issues Emerg Health Technol. 2008 Feb;(113):1-6.

PMID:
18354858
17.

Anemia in chronic heart failure: etiology and treatment options.

Westenbrink BD, de Boer RA, Voors AA, van Gilst WH, van Veldhuisen DJ.

Curr Opin Cardiol. 2008 Mar;23(2):141-7. doi: 10.1097/HCO.0b013e3282f43025. Review.

PMID:
18303527
18.

The effects of erythropoiesis stimulating therapy for anemia in chronic heart failure: A meta-analysis of randomized clinical trials.

Kang J, Park J, Lee JM, Park JJ, Choi DJ.

Int J Cardiol. 2016 Sep 1;218:12-22. doi: 10.1016/j.ijcard.2016.04.187. Epub 2016 May 11.

PMID:
27209352
19.

Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis.

Desai A, Lewis E, Solomon S, McMurray JJ, Pfeffer M.

Eur J Heart Fail. 2010 Sep;12(9):936-42. doi: 10.1093/eurjhf/hfq094. Epub 2010 Jun 5. Review.

20.

Erythropoietic stimulating agents.

Testa U.

Expert Opin Emerg Drugs. 2010 Mar;15(1):119-38. doi: 10.1517/14728210903499273. Review.

PMID:
20158404

Supplemental Content

Support Center